Search

Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control

Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 303-309
Author(s): Junya Kuroda, Masafumi Taniwaki

Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar

Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL

Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 530-536
Author(s): Massimo Breccia, Giuliana Alimena

Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 8 Year: 2009 Page: 853-863
Author(s): Manlio Tolomeo, Francesco Dieli, Nicola Gebbia, Daniele Simoni

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 120-133
Author(s): Bernhard A. Muller

Resistance to Imatinib in Chronic Myeloid Leukemia and Therapeutic Approaches to Circumvent the Problem

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 1 Year: 2009 Page: 21-28
Author(s): Massimo Breccia, Giuliana Alimena

Towards Cure of CML: Why We Need to Know More About CML Stem Cells?

Journal: Current Stem Cell Research & Therapy
Volume: 4 Issue: 3 Year: 2009 Page: 224-236
Author(s): Jeroen J.W.M. Janssen, Gerrit J. Schuurhuis, Monique Terwijn, Gerrit J. Ossenkoppele

Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 66-76
Author(s): Dariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, Deborah Ferriola, Ireneusz Majsterek

The Novel Role for Lyn in Integrin Signaling in Human Disease

Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 1 Year: 2009 Page: 59-65
Author(s): Brian Tomkowicz, Andrzej Ptasznik

Interaction of ABC Multidrug Transporters with Anticancer Protein Kinase Inhibitors: Substrates and/or Inhibitors?

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 252-272
Author(s): Csilla Ozvegy-Laczka, Csilla Hegedus, Gergely Szakacs, Balazs Sarkadi